Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3015822	s-parvnho	— (—)	185	207	99.03%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L04AD Calcineurin inhibitors

43.80

87.17

1.2

1.1

—

Aplastic and other anaemias

14.50

71.82

1.2

1.1

—

Other and unspecified anaemias

14.81

68.33

1.2

1.1

—

Other anaemias

14.77

68.11

1.2

1.1

—

Other diseases of blood and blood-forming organs, wide

21.84

67.51

1.1

1.0

—

Bacterial infection, other or unspecified, including avohilmo

11.23

53.98

1.2

1.0

—

Bacterial infection, other or unspecified

11.79

53.80

1.1

1.0

—

Septicaemia

11.16

39.82

1.1

1.0

—

Explicit Sepsis

8.42

35.64

1.1

—

Other septicaemia

10.52

34.57

1.1

1.0

—

Explicit Sepsis, including avohilmo

8.07

34.40

1.1

—

Other septicaemia, including avohilmo

10.18

33.74

1.1

1.0

—

Transplanted organ and tissue status

35.76

30.55

1.4

1.1

—

L04AA Selective immunosuppressants

10.34

29.76

1.3

1.1

—

Anaemias

32.11

26.72

1.2

1.3

—

Chronic kidney disease

8.15

24.51

1.4

1.0

—

Renal failure

6.21

23.98

1.3

1.0

—

Bacterial Sepsis

7.01

23.93

1.1

1.0

—

Purpura and other haemorrhagic conditions

28.30

23.12

1.0

1.2

—

Agranulocytosis

30.15

20.53

1.1

—

Implicit bacterial Sepsis

6.70

19.18

1.1

1.0

—

All chronic kidney diseases

5.23

18.36

1.3

1.1

—

Thrombocytopenia, unspecified

36.92

17.60

1.0

—

Implicit bacterial Sepsis, including avohilmo

5.84

17.24

1.1

1.0

—

Other viral diseases

6.26

16.17

1.5

1.1

—

Implicit Sepsis

4.48

15.83

1.1

1.0

—

Dialysis, with operation codes

15.70

15.68

1.5

1.0

—

GASTRO-related operations

5.61

15.19

1.1

—

Any gastric operation

5.61

15.19

1.1

—

Nephropathy related operations

13.95

14.98

1.5

1.0

—

Covid-19 confirmed case

5.18

14.31

1.4

1.1

—

Implicit Sepsis, including avohilmo

3.93

13.98

1.1

—

Other medical care

4.88

13.96

1.2

1.1

—

Other viral diseases, including avohilmo

4.72

13.31

1.4

1.0

—

Care involving dialysis

16.76

12.97

1.5

1.0

—

Kidney transplant status

24.45

12.46

1.6

1.0

—

ILD medications: azathioprine

20.05

12.43

1.6

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.59

11.76

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

16.41

11.64

1.1

1.0

—

Other autoimmune haemolytic anaemias

+∞

11.50

1.1

0.0

—

Glomerular diseases

9.19

10.97

1.4

1.0

—

Implicit viral Sepsis, including avohilmo

5.71

10.95

1.2

1.0

—

Cerebrovascular diseases (FINNGEN)

6.37

10.54

1.1

—

Candidiasis, including avohilmo

4.61

9.98

1.0

1.1

—

Lymphoid leukaemia

21.78

9.35

1.0

—

Azathioprine

9.49

9.25

1.6

1.1

—

Glomerular disorders in diseases classified elsewhere

10.03

9.01

1.5

1.1

—

Infections, IBD-co-morbidities

10.55

9.00

1.0

1.2

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

12.54

8.85

1.0

1.1

—

Drug-induced neutropenia

16.32

8.54

1.0

—

All influenza

6.26

7.98

1.0

—

Malaise and fatigue

4.02

7.89

1.1

1.0

—

Implicit viral Sepsis

6.93

7.75

1.2

1.0

—

Viral Sepsis

6.93

7.75

1.2

1.0

—

Extracorporeal dialysis

15.06

7.71

1.2

1.0

—

Implicit fungal Sepsis, including avohilmo

15.05

7.71

1.1

1.0

—

Other bacterial intestinal infections

8.01

7.58

1.1

—

STROKE

3.49

7.56

1.0

1.1

—

Systemic connective tissue disorders

3.89

7.41

1.1

—

Bacterial intestinal infections, IBD co-morbidities

7.63

7.37

1.1

1.0

—

Other and unspecified acquired haemolytic anaemias

+∞

7.31

1.1

0.0

—

Abnormal findings on examination of blood, without diagnosis

3.43

7.19

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

101

2.52

7.08

1.1

—

Cutaneous abscess, furuncle and carbuncle

4.05

7.06

1.1

—

Rheumatoid arthritis

4.10

6.95

1.1

—

Acute renal failure

6.30

6.92

1.1

1.0

—

Abnormal findings on diagnostic imaging of lung

3.34

6.74

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.84

6.74

1.1

—

Viral pneumonia

8.68

6.54

1.1

—

Immunodeficiencies

14.35

6.39

1.1

—

Enlarged lymph nodes

11.01

6.29

1.0

1.1

—

Acquired pure red cell aplasia [erythroblastopenia]

+∞

6.29

2.2

0.0

—

Dialysis

18.09

6.26

1.1

1.0

—

Preparatory care for dialysis

18.08

6.26

2.1

1.0

—

Nonhereditary hypogammaglobulinemia

+∞

6.26

1.2

0.0

—

L01XE Protein kinase inhibitors

18.07

6.26

1.0

—

Certain disorders involving the immune mechanism

6.26

6.15

1.2

1.0

—

Other bacterial intestinal infections, including avohilmo

5.52

5.97

1.1

1.0

—

Gingival hyperplasia

15.08

5.90

1.1

1.0

—

Other (seronegative) rheumatoid arthritis, wide

6.37

5.85

1.0

—

Cerebrovascular diseases

2.72

5.75

1.3

1.1

—

Noninfectious colitis NAS

7.51

5.62

1.3

1.1

—

Candidiasis

6.51

5.54

1.0

1.1

—

Bacterial pneumonia (organism specified)

3.17

5.41

1.2

1.1

—

Secondary hypertension

15.79

5.36

2.0

1.0

—

Mycoses

3.54

5.31

1.0

1.1

—

Rheumatoid arthritis, including avohilmo

3.28

5.29

1.1

—

Haemophagocytic lymphohistiocytosis

+∞

5.29

1.6

0.0

—

Non-follicular lymphoma

9.11

5.28

1.0

—

Explicit bacterial Sepsis

9.10

5.28

1.2

1.0

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

+∞

5.24

1.6

0.0

—

Other and unspecified immunodeficiencies with predominantly antibody defects

+∞

5.22

1.2

0.0

—

Primary Sclerosing Cholangitis, IBD and UDCA required

+∞

5.21

1.0

0.0

—

Nutritional anaemias

2.77

5.21

1.0

1.1

—

Hypoplasia of dental enamel

+∞

5.21

1.2

0.0

—

Budesonide

7.34

5.13

1.1

—

Other infectious diseases, including avohilmo

8.35

5.05

1.2

1.1

—

Explicit bacterial Sepsis, including avohilmo

8.34

5.05

1.2

1.0

—

Other noninfective gastroenteritis and colitis

4.44

5.03

1.3

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

5.00

4.93

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

2.86

4.90

1.1

1.0

—

Erysipelas

3.30

4.89

1.1

1.0

—

Bacterial pneumoniae

3.39

4.84

1.2

1.0

—

Oedema, not elsewhere classified

4.23

4.80

1.5

1.1

—

Other necrotizing vasculopathies

11.45

4.78

1.3

1.0

—

Enterocolitis due to Clostridium difficile

9.01

4.78

1.0

—

Stroke, excluding SAH

2.73

4.77

1.0

1.1

—

Other viral diseases, not elsewhere classified, including avohilmo

3.55

4.71

1.6

1.1

—

Bacterial pneumonia, not elsewhere classified

3.43

4.63

1.2

1.0

—

Stroke, including SAH

2.63

4.62

1.0

1.1

—

ILD, hospital admissions 3, with pneumonia sepsis

14.02

4.57

1.1

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

3.14

4.36

1.1

—

Syncope and collapse

3.26

4.25

1.1

1.0

—

Seronegative rheumatoid arthritis

6.93

4.16

1.0

1.1

—

Diabetic nephropathy

5.18

4.09

1.6

1.1

—

Other infectious diseases

8.02

4.06

1.3

1.0

—

Streptococcal septicaemia

8.01

4.06

1.1

1.0

—

Streptococcal septicaemia, including avohilmo

8.01

4.06

1.1

1.0

—

Ischaemic Stroke, excluding all haemorrhages

2.65

4.04

1.0

1.1

—

L04AC Interleukin inhibitors

10.02

4.01

1.0

1.1

—

Infectious mononucleosis, including avohilmo

6.44

3.98

1.2

1.1

—

Infectious mononucleosis

6.44

3.98

1.2

1.1

—

Actinic keratosis

3.03

3.90

1.1

—

Secondary uncertain malignant neoplasm

7.28

3.85

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.30

3.84

1.1

—

2.89

3.81

1.1

—

Personal history of other diseases and conditions

5.98

3.79

1.1

—

ILD, hospital admission 2, with pulmonary infections

8.76

3.77

1.1

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

3.07

3.76

1.5

1.1

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

12.04

3.76

1.0

—

Cholangitis (primary sclerosing, PSC)

12.02

3.76

1.0

—

Diabetic nephropathy, excluding more controls

4.72

3.70

1.6

1.2

—

Hypoplasia of dental enamel , including avohilmo

11.57

3.67

1.2

1.0

—

Molar incisor enamel hypoplasia

11.50

3.66

1.2

1.0

—

Other problems related to primary support group, including family circumstances

4.87

3.59

1.3

1.1

—

Other gastritis (incl. Duodenitis)

4.00

3.59

1.1

1.0

—

Other viral diseases, not elsewhere classified

3.99

3.57

1.8

1.1

—

Zoster [herpes zoster]

4.77

3.55

1.1

1.0

—

Bleeding

107

2.10

3.54

1.1

—

Diseases of arteries, arterioles and capillaries

2.32

3.54

1.3

1.1

—

Acute bronchitis

2.64

3.51

1.1

—

Other disorders of kidney and ureter

5.30

3.50

1.1

1.0

—

Other embolism and thrombosis

5.30

3.50

1.1

—

Glomerulonephritis

6.16

3.50

1.1

1.0

—

Other necrotizing vasculopathies (FG)

10.02

3.49

1.2

1.0

—

Other diseases of biliary tract

10.01

3.49

1.0

—

Supervision of high-risk pregnancy

4.25

3.47

1.0

1.5

—

DVT of lower extremities

4.55

3.42

1.0

—

Sequelae of external causes of morbidity and mortality

3.52

3.39

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

8.17

3.39

1.1

1.2

—

Biological medication for rheuma

4.08

3.39

1.0

1.1

—

Unspecified kidney failure

7.01

3.36

1.3

1.0

—

Certain conditions originating in the perinatal period

5.92

3.34

1.9

1.1

—

Viral and other specified intestinal infections, including avohilmo

3.48

3.34

1.8

1.1

—

Presence of other functional implants

2.60

3.34

1.0

1.1

—

Methotrexate

5.72

3.34

1.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

5.72

3.34

1.0

—

Sequelae with surgical and medical care as external cause

3.93

3.28

1.0

—

Other skin changes

3.93

3.28

1.0

—

Other infective otitis externa

8.59

3.26

1.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes

8.58

3.26

1.0

—

Other acute lower respiratory infections

2.26

3.26

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

4.60

3.25

1.0

—

ILD, hospital admissions 1, main diag only

5.34

3.19

1.3

1.0

—

Iron deficiency anaemia

2.49

3.15

1.0

1.1

—

Other respiratory diseases principally affecting the interstitium

4.50

3.11

1.2

1.0

—

Other specified/unspecified bacterial intestinal infections

7.51

3.05

1.3

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

5.01

3.05

1.0

1.1

—

Depression medications

4.57

3.03

1.1

1.2

—

Dysphagia

3.34

3.01

1.0

1.1

—

Other encephalitis

10.04

2.98

1.2

1.0

—

Encephalitis

10.03

2.98

1.2

1.0

—

Other inflammatory liver diseases

10.01

2.98

1.0

—

Other or ill-defined heart diseases

10.01

2.98

1.0

—

Diseases of liver

2.63

2.96

1.0

1.1

—

Coeliac disease

4.71

2.91

1.0

1.1

—

ILD, hospital admissions

4.71

2.91

1.3

1.0

—

Other interstitial pulmonary diseases

4.71

2.91

1.3

1.0

—

Interstitial lung disease endpoints

4.71

2.91

1.3

1.0

—

Interstitial lung disease

4.71

2.91

1.3

1.0

—

Pleural effusion

4.71

2.91

1.1

1.0

—

Osteopathies and chondropathies

2.19

2.89

1.3

1.1

—

Disorders of other endocrine glands

2.31

2.87

1.1

1.0

—

Undetermined asthma

6.66

2.86

1.0

1.1

—

Malignant neoplasm of skin, including Hilmo

2.71

2.85

1.0

1.1

—

Diseases of the digestive system

2.30

2.85

1.0

—

Seropositive rheumatoid arthritis

3.32

2.79

1.1

1.2

—

Otitis externa

3.08

2.76

1.0

1.1

—

Polyarthritis, unspecified

8.36

2.75

1.0

—

Multiple myeloma and malignant plasma cell neoplasms

8.35

2.75

1.4

1.0

—

Suppurative and necrotic conditions of lower respiratory tract

8.35

2.75

1.0

—

Acute peritonitis

8.35

2.75

1.0

—

Sequelae of cerebrovascular disease

2.78

2.73

1.5

1.0

—

Convulsions, not elsewhere classified

3.87

2.73

1.0

1.1

—

Ovarian dysfunction

5.01

2.72

1.0

1.1

—

Other and unspecified urticaria

3.24

2.72

1.1

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

6.01

2.70

1.2

1.0

—

Undetermined asthma, excluding more controls

6.00

2.69

1.0

1.1

—

Other metabolic disorders

4.21

2.67

1.0

1.1

—

Other diseases of pleura

2.44

2.66

1.1

1.0

—

Benign neoplasm: Colon

2.23

2.65

1.1

—

Peripheral artery disease

2.63

2.64

1.6

1.0

—

Urticaria and erythema

2.39

2.62

1.1

—

Other disorders of lacrimal gland

2.46

2.61

1.1

1.0

—

Diseases of external ear

2.46

2.61

1.0

1.1

—

Nonsuppurative otitis media

2.81

2.60

1.0

1.1

—

Abnormal findings on antenatal screening of mother

4.67

2.59

1.0

1.2

—

Early onset COPD, excluding more controls

4.66

2.59

1.1

1.0

—

Maternal care for known or suspected fetal abnormality and damage

3.39

2.58

1.7

1.2

—

Hyperkinetic disorders, excluding more controls

3.65

2.58

1.1

—

Noninfective enteritis and colitis

2.18

2.55

1.2

1.0

—

Benign neoplasm: Skin of trunk

7.16

2.55

1.0

—

Acute generalized exanthematous pustulosis

7.16

2.55

1.2

1.0

—

Juvenile arthritis (FINNGEN)

7.16

2.55

1.0

1.3

—

Other otitis externa (chronic)

7.15

2.55

1.0

—

Amputation

7.14

2.55

2.4

1.0

—

Hypo-osmolality and hyponatraemia

3.97

2.54

1.0

—

Invasive ventilation

5.46

2.54

1.0

—

Peripheral artery operations in Hilmo

5.46

2.54

2.2

1.0

—

Osteoporosis

3.06

2.54

1.0

1.1

—

Pain, not elsewhere classified

3.23

2.51

1.1

—

Chronic periodontitis, complicated

2.12

2.50

1.4

1.1

—

Seropositive rheumatoid arthritis, wide

2.97

2.48

1.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

3.46

2.48

1.0

—

Maternal care for other known or suspected fetal problems

2.72

2.45

1.6

1.2

—

Acute pharyngitis

3.43

2.45

1.1

—

Melanocytic naevi

2.55

2.44

1.1

—

Other and unspecified iron deficiency

2.45

2.43

1.0

1.1

—

Pre-eclampsia or eclampsia

3.13

2.43

1.7

1.1

—

Diseases of the respiratory system

2.23

2.42

1.1

1.2

—

Disturbance of activity and attention

3.38

2.41

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

5.01

2.40

1.2

—

Adalimumab

5.00

2.40

1.0

1.2

—

Inflammatory diseases of the central nervous system

5.01

2.40

1.2

1.0

—

Other specified/unspecified hearing loss

6.26

2.37

1.0

—

Symptoms and signs concerning food and fluid intake

6.24

2.37

1.0

1.1

—

Car occupant injured in other and unspecified transport accidents

3.03

2.35

1.7

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

2.04

2.34

1.0

1.1

—

Other hearing loss

3.03

2.34

1.0

—

Nausea and vomiting

2.60

2.33

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

117

1.87

2.31

1.3

1.1

—

Basal cell carcinoma, including Hilmo

2.59

2.30

1.0

1.1

—

Herpesviral [herpes simplex] infections

4.62

2.27

1.0

1.1

—

Asthma-related pneumonia

2.37

2.27

1.0

1.1

—

Asthma-related pneumonia or sepsis

2.37

2.27

1.0

1.1

—

Asthma, hospital admissions 3, pneumonia

2.37

2.27

1.0

1.1

—

Hyperkinetic disorders

3.14

2.24

1.1

—

Pre-eclampsia

3.11

2.22

1.8

1.1

—

Other/unspecified rheumatoid arthritis

5.56

2.21

1.0

—

Disorders of lens

2.03

2.19

1.0

—

Malignant neoplasm of skin

2.51

2.19

1.0

1.1

—

Atrial fibrillation and flutter

3.23

2.17

1.0

1.1

—

Fracture of lumbar spine and pelvis

3.33

2.17

1.0

—

Diseases of the myoneural junction and muscle

4.29

2.15

1.0

—

Cholecystitis

3.69

2.15

1.0

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

3.00

2.14

1.2

1.0

—

Other benign neoplasms of skin

2.30

2.14

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.78

2.13

1.1

—

Gout, FINNGEN

2.76

2.11

1.0

—

Factors influencing health status and contact with health services

3.65

2.11

1.1

1.0

—

Calcific aortic valvular stenosis, operated

2.75

2.10

1.0

—

Calcific aortic valvular stenosis

2.75

2.10

1.0

—

Operations 2 for CAVS

2.75

2.10

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.75

2.10

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

2.75

2.09

1.0

—

Myeloproliferative diseases

5.01

2.07

1.0

—

Elevated blood glucose level

5.01

2.07

1.2

1.0

—

Pyogenic arthritis

5.01

2.07

1.0

—

Disorders of mineral metabolism

5.00

2.07

1.0

—

Diseases of peritoneum

5.00

2.07

1.0

—

Viral warts

5.00

2.07

1.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis

2.70

2.06

1.1

—

Ulcer of lower limb, not elsewhere classified

3.50

2.05

2.1

1.0

—

Other and unspecified drugs and medicaments

4.00

2.04

1.2

1.1

—

Other keratitis

4.00

2.04

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

100

1.90

2.00

1.4

1.1

—

Basal cell carcinoma

2.48

1.98

1.0

1.1

—

Hypotension

3.33

1.96

1.1

1.0

—

Keratitis

2.19

1.94

1.0

1.1

—

In situ neoplasms

2.19

1.94

1.1

—

Gout

2.60

1.94

1.0

—

Adverse effects, not elsewhere classified

2.73

1.93

1.1

—

Presbycusis

4.49

1.92

1.0

—

Nonsuppurative otitis media, including avohilmo

2.20

1.91

1.0

1.1

—

Coxarthrosis [arthrosis of hip](FG)

2.12

1.91

1.0

1.1

—

Peripheral arterial reconstruction

3.18

1.88

1.0

—

Other disorders starting during childhood or adolecense, excluding more controls

4.34

1.86

1.2

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.39

1.86

1.0

1.1

—

Stomatitis and related lesions

2.65

1.86

1.0

1.1

—

Open wound of lower leg

2.86

1.86

1.3

1.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3.53

1.83

1.0

—

Special screening examination for other diseases and disorders

3.53

1.83

1.0

1.1

—

Benign neoplasm: Caecum

4.17

1.82

1.0

—

Disorders of muscles

4.17

1.82

1.0

1.1

—

Family history of malignant neoplasm

4.17

1.82

1.0

1.1

—

Malignant melanoma

4.17

1.82

1.0

—

Childhood asthma (age<16)

4.34

1.81

1.0

1.1

—

Childhood asthma (age<16), excluding more controls

4.34

1.81

1.0

1.1

—

Urticaria

2.26

1.80

1.1

—

Other CVD (FINNGEN)

4.24

1.77

1.2

1.0

—

Disorders of lacrimal system

1.99

1.77

1.1

—

Crohn disease

3.34

1.74

1.2

1.1

—

Nontraumatic intracranial haemmorrhage

3.33

1.74

1.0

—

Rash and other nonspecific skin eruption

3.85

1.71

1.4

1.1

—

Seborrhoeic dermatitis

3.85

1.71

1.0

1.1

—

Disorders of parathyroid gland

2.88

1.69

1.1

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.06

1.69

1.0

1.1

—

Myocardial infarction

2.05

1.69

1.0

1.1

—

Dizziness and giddiness

108

1.73

1.69

1.4

1.1

—

Diverticular disease of intestine

1.86

1.68

1.1

—

Zoster [herpes zoster], including avohilmo

1.91

1.67

1.3

1.0

—

Viral and other specified intestinal infections

2.60

1.67

1.1

—

Other disorders of ear

114

1.64

1.66

1.0

1.1

—

Other CVD

2.80

1.65

1.1

1.0

—

Hyperparathyroidism

3.12

1.64

1.2

1.0

—

Functional dyspepsia

2.44

1.64

1.8

1.0

—

Disturbances of skin sensation

2.44

1.64

1.8

1.1

—

Atrial fibrillation and flutter with reimbursement

2.94

1.63

1.0

—

Haemorrhage from respiratory passages

2.26

1.62

1.2

1.1

—

Malignant melanoma, including Hilmo

3.57

1.61

1.0

1.1

—

Myocardial infarction, strict

2.06

1.61

1.0

1.1

—

Lyme disease

2.14

1.60

1.1

—

Lyme disease, including avohilmo

2.14

1.60

1.1

—

Other inflammation of eyelid

3.00

1.58

1.2

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.00

1.58

1.0

1.1

—

Other and unspecified polyneuropathies, also in other diseases

2.69

1.58

1.1

1.0

—

Senile cataract

1.91

1.56

1.0

—

Persons encountering health services in other circumstances

2.04

1.55

1.0

1.1

—

Other spirochaetal diseases

2.11

1.54

1.1

—

Diagnoses used for exclusion with ILD

2.42

1.53

1.1

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.22

1.52

1.0

—

Coxarthrosis

1.98

1.52

1.0

1.1

—

Ectopic pregnancy

2.59

1.51

1.1

1.0

—

Gout, strict definition

2.59

1.51

1.0

—

Other disorders starting during childhood or adolescence

3.30

1.50

1.2

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.86

1.50

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.27

1.49

1.2

1.1

—

Cellulitis

2.43

1.47

1.2

1.1

—

Hypertensive heart and/or renal disease

2.43

1.47

1.0

—

Sulfasalazine

2.37

1.45

1.0

—

Chronic gastritis

2.37

1.45

1.1

—

Diaphragmatic hernia

2.12

1.44

1.0

1.1

—

Sarcoidosis

3.13

1.44

1.2

1.1

—

Thoracic aortic aneurysm

3.13

1.44

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.18

1.43

1.0

1.1

—

Spirochaetal infections, other/unspecified, including avohilmo

2.03

1.43

1.1

—

Other spirochaetal diseases, including avohilmo

2.03

1.43

1.1

—

Continuous positive airway pressure

2.78

1.43

1.2

1.1

—

Abnormal serum enzyme levels

2.19

1.41

1.0

—

Other and unspecified effects of external causes

2.17

1.39

1.1

—

Other/unspecified dorsalgia

1.89

1.38

1.1

—

Other functional intestinal disorders

1.90

1.37

1.1

—

Insulin, fast-acting or short human

1.94

1.37

1.7

1.1

—

Ischaemic heart disease, wide definition

1.70

1.37

1.0

1.1

—

Mucosal proctocolitis

2.94

1.36

1.0

1.1

—

Hydrocele

2.94

1.36

1.0

—

All influenza (not pneumonia)

2.94

1.36

1.0

1.1

—

Diabetic retinopathy, strict definition

2.39

1.35

2.1

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

2.94

1.35

1.0

—

Herpesviral [herpes simplex] infections, including avohilmo

2.14

1.33

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.04

1.32

1.0

1.1

—

Spontaneous abortion

1.82

1.32

1.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2.53

1.31

1.0

1.1

—

Colonic or urogenital fistula

2.09

1.30

1.0

—

Superficial injury of wrist and hand

2.35

1.29

1.0

1.1

—

Covid-19 suspected case

2.35

1.29

1.0

1.1

—

Myocardial infarction, without ST-elevation

2.03

1.28

1.0

—

Postpartum haemorrhage due to retained placenta

2.78

1.28

1.2

1.1

—

Ulcerative colitis, NAS

2.78

1.28

1.0

1.1

—

Insulin, fast-acting

1.88

1.28

1.7

1.1

—

Insulin, intermediate and long-acting

1.73

1.28

1.5

1.1

—

Other systemic involvement of connective tissue

2.05

1.26

1.0

1.1

—

Recurrent aphthous stomatitis , including avohilmo

2.40

1.24

1.0

1.1

—

Inflammatory bowel disease

1.96

1.22

1.1

—

Ulcerative colitis

2.16

1.21

1.1

—

Congenital malformations and deformations of the musculoskeletal system

2.62

1.21

1.0

1.1

—

Other systemic involvement of connective tissue (FG)

2.12

1.19

1.0

1.2

—

Disorders of choroid and retina

103

1.56

1.16

1.4

1.1

—

Presence of cardiac and vascular implants and grafts

2.04

1.16

1.0

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.08

1.15

1.1

1.0

—

Major coronary heart disease event excluding revascularizations

1.73

1.15

1.0

—

Fissure and fistula of anal and rectal regions

2.05

1.15

1.0

1.1

—

Outcome of delivery

2.56

1.11

1.0

1.8

—

Missing teeth due to accident, extraction or parodontitis

1.62

1.10

1.2

1.0

—

Postmenopausal bleeding

2.29

1.09

1.0

1.2

—

Postpartum haemorrhage due to anatomy

2.38

1.09

1.2

1.0

—

Atrophic disorders of skin

2.38

1.09

1.0

1.1

—

Somatoform disorder

2.38

1.09

1.4

1.1

—

Benign neoplasm: Sigmoid colon

2.38

1.09

1.0

—

Acne, including avohilmo

1.97

1.09

1.2

1.0

—

Primary coxarthrosis, bilateral

1.95

1.08

1.0

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

2.37

1.08

1.0

1.1

—

Gastroduodenal ulcer

2.18

1.07

1.0

—

Malignant neoplasm of digestive organs, including Hilmo

2.07

1.07

1.0

1.1

—

Early onset COPD

2.12

1.05

1.1

1.0

—

Viral warts, including avohilmo

2.12

1.05

1.0

1.1

—

Other retinal disorders

1.61

1.04

1.5

1.1

—

Hypertensive Heart Disease

2.12

1.04

1.0

—

Maternal care for known or suspected abnormality of pelvic organs

1.96

1.03

1.0

1.2

—

Salpingitis and oophoritis

2.27

1.03

1.0

1.1

—

Pregnancy examination and test

2.38

1.03

1.2

1.7

—

Migraine with aura and triptan purchases

2.06

1.02

1.0

1.1

—

Gout, idiopatic and unspecified

2.06

1.02

1.0

—

Benign neoplasm: Colon, unspecified

2.06

1.02

1.0

—

Complications predominantly related to the puerperium

1.92

1.02

1.1

—

Other neurological diseases

100

1.55

1.01

1.5

1.1

—

Pacemaker

1.90

1.01

1.0

—

Other diseases of the digestive system

1.88

1.00

1.0

—

Other strabismus

1.99

0.99

1.1

—

Emotionally unstable personality disorder

2.17

0.98

1.0

1.1

—

Hypertrophy of breast

0.00

0.97

0.0

1.1

—

Postmenopausal atrophic vaginitis

2.01

0.96

1.0

1.3

—

Diseases of salivary glands

1.85

0.96

1.7

1.1

—

Hypertrophy of breast in women and men

0.00

0.95

0.0

1.1

—

Aortic aneurysm

2.26

0.94

1.0

—

IBD patients in KELA-register

1.89

0.94

1.1

—

Other diseases of anus and rectum

1.76

0.94

1.0

1.1

—

Acute appendicitis, with complications

2.22

0.93

1.5

1.0

—

Medical abortion

0.53

0.92

1.1

—

Symptoms and signs involving the urinary system

106

1.49

0.92

1.1

1.0

—

Tumor necrosis factor alpha inhibitors

2.14

0.91

1.0

1.1

—

Other noninflammatory disorders of uterus, except cervix

2.11

0.89

1.0

1.3

—

D07AA Corticosteroids, weak (group I)

2.07

0.89

1.0

1.1

—

Myalgia

1.91

0.88

1.0

—

Conductive and sensorineural hearing loss

1.48

0.88

1.0

1.1

—

Other diseases of lip and oral mucosa

1.65

0.87

1.0

1.1

—

Coxarthrosis, primary, with hip surgery

1.69

0.87

1.0

1.1

—

Nontoxic multinodular goitre

2.00

0.87

1.3

1.1

—

Gout, unspecified

2.00

0.87

1.0

—

Conduction disorders

1.83

0.86

1.0

1.1

—

Other disorders of veins

1.72

0.85

1.1

—

COPD, hospital admission 2, with asthma infections

1.72

0.81

1.1

1.0

—

Supervision of normal pregnancy

1.90

0.80

1.2

1.5

—

Other cataract

1.70

0.80

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.72

0.79

1.0

1.1

—

Excessive earwax

112

0.57

0.78

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.57

0.77

1.1

1.0

—

Antenatal screening

1.96

0.77

1.1

1.5

—

Abnormal involuntary movements

2.08

0.74

1.0

1.1

—

Other condition

2.08

0.74

1.0

1.1

—

Other symptoms and signs involving the digestive system and abdomen

2.08

0.74

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.67

0.74

1.0

1.1

—

Voice disturbances

1.84

0.73

1.0

1.1

—

Disorders of psychological development

2.02

0.73

1.2

1.1

—

Inflammatory bowel disease, strict (require KELA)

1.80

0.72

1.1

—

Fracture of foot, except ankle

1.80

0.72

1.3

1.1

—

Malignant neoplasm of digestive organs

1.78

0.72

1.0

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.61

0.72

1.2

1.1

—

Premature rupture of membranes

1.78

0.72

1.0

1.1

—

Cough

1.67

0.71

1.1

—

Poisoning by drugs, medicaments and biological substances

1.75

0.71

1.0

1.1

—

Pain in thoracic spine

1.92

0.70

1.4

1.1

—

Propionic acid derivatives

0.51

0.70

1.0

1.1

—

severe traumatic brain injury, does not include concussion

1.92

0.70

1.0

—

Specific personality disorders

1.71

0.69

1.0

1.1

—

Polycystic ovarian syndrome, broad definition

1.85

0.68

1.0

1.1

—

Follicular cysts of skin and subcutaneous tissue

1.85

0.68

1.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.85

0.68

1.0

—

Strabismus

1.66

0.68

1.1

—

Calculus of kidney and ureter

1.63

0.66

1.0

—

Panic disorder

1.79

0.66

1.0

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.79

0.66

1.0

1.1

—

GI-bleeding

1.63

0.62

1.0

—

Superficial injury of abdomen, lower back and pelvis

1.67

0.61

1.0

1.1

—

Bipolar affective disorders

1.67

0.61

1.0

1.1

—

Use of pramipexole

1.67

0.61

1.0

—

Fracture of femur

1.67

0.61

1.4

1.0

—

Parkinson's disease, excluding more controls

0.00

0.60

0.0

1.0

—

Conjunctivitis (acute, non atopic)

1.56

0.60

1.1

—

Sensorineural hearing loss

1.39

0.60

1.0

1.1

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.59

0.0

1.0

—

Coxibs

0.56

0.59

1.0

1.1

—

Acetic acid derivatives and related substances

0.54

0.58

1.0

1.1

—

Trigger finger

0.00

0.58

0.0

1.0

—

Fracture of skull and facial bones

1.71

0.57

1.2

1.1

—

Other extrapyramidal and movement disorders in other diseases

1.71

0.57

1.0

—

Anomalies of dental arch relationship, including avohilmo

1.70

0.57

1.0

1.1

—

Symptoms and signs involving speech and voice

1.48

0.57

1.1

—

COPD

1.56

0.56

1.1

1.0

—

Fibroblastic disorders

1.67

0.56

1.3

1.0

—

Childhood allergy (age < 16)

1.65

0.56

1.0

1.1

—

Disorders of adult personality and behaviour

1.45

0.56

1.0

1.1

—

Substance use, excluding alcohol

1.62

0.55

1.0

1.1

—

Other arthrosis

1.49

0.55

1.0

1.1

—

Fall on and from stairs and steps

1.58

0.54

1.0

1.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.50

0.51

1.0

1.1

—

Diabetic retinopathy, excluding more controls

1.63

0.51

2.1

1.2

—

Unspecified haematuria

1.51

0.50

1.2

1.0

—

Embedded and impacted teeth

1.50

0.49

1.0

1.1

—

Meniscus derangement

1.45

0.49

1.0

1.1

—

Angina pectoris

1.45

0.49

1.0

1.1

—

Impacted teeth

1.50

0.48

1.0

1.1

—

Personality disorders, excluding more controls

1.49

0.47

1.0

1.1

—

Personality disorders

1.46

0.46

1.0

1.1

—

Fracture of rib(s), sternum and thoracic spine

1.46

0.46

1.1

1.0

—

Urolithiasis

1.43

0.46

1.0

—

Disorders of refraction and accommodation

1.42

0.45

1.3

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

0.62

0.44

1.0

1.1

—

malignant neoplasm of male genital organs

1.67

0.44

1.0

1.1

—

malignant neoplasm of male genital organs, including Hilmo

1.67

0.44

1.0

1.1

—

Injuries to the thorax

1.39

0.44

1.1

1.0

—

Malignant neoplasm of prostate

1.64

0.44

1.0

1.1

—

Malignant neoplasm of prostate, including Hilmo

1.64

0.44

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1.62

0.43

1.6

1.0

—

Other disorders of bone

1.61

0.43

1.0

1.1

—

Spondylosis

0.63

0.42

1.2

1.0

—

Disorders of vitreous body and globe

1.38

0.42

1.2

1.1

—

Coronary atherosclerosis

1.36

0.42

1.1

—

Coxarthrosis, primary

1.37

0.42

1.0

1.1

—

Transient ischemic attack

1.41

0.42

1.1

—

Septal defects

0.00

0.41

0.0

1.1

—

Paralytic ileus and intestinal obstruction

1.51

0.41

1.2

1.0

—

L02BB Anti-androgens

0.00

0.41

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.41

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.41

0.0

1.2

—

Tooth eruption problems

1.51

0.41

1.2

1.0

—

Achilles tendinitis

0.00

0.41

0.0

1.1

—

FESS (DNB20)

0.00

0.41

0.0

1.1

—

Ethmoidectomy

0.00

0.41

0.0

1.1

—

Use of levodopa decarboxylase inhibitor

0.00

0.41

0.0

1.0

—

Parkinson's disease, strict definition

0.00

0.41

0.0

1.0

—

Parkinson's disease

0.00

0.41

0.0

1.0

—

Congenital malformations of genital organs

0.00

0.41

0.0

1.2

—

Retinal detachments and breaks

1.36

0.41

1.0

—

Multiple delivery

0.00

0.40

0.0

1.5

—

LSIL lesion of the cervix uteri

0.00

0.40

0.0

1.2

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.40

0.0

1.1

—

Type 1 diabetes, definitions combined

0.00

0.40

0.0

1.1

—

Thiazolidinediones

0.00

0.40

0.0

1.0

—

Abrasion of teeth

1.31

0.39

1.3

1.1

—

Maternal care for known or suspected malpresentation of fetus

1.43

0.39

1.0

1.2

—

Benign leiomyoma with endometriosis

0.00

0.39

0.0

1.2

—

Parkinson's disease, including avohilmo

0.00

0.39

0.0

1.0

—

Status post-ami

1.40

0.38

1.0

—

Poisoning by medicine

1.39

0.38

1.0

1.1

—

Seborrhoeic keratosis

1.35

0.37

1.0

—

Cervicobrachial syndrome

1.35

0.37

1.0

1.1

—

Striking against or struck by other objects

1.30

0.37

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative

1.49

0.37

1.0

1.2

—

Malignant neoplasm of breast

1.43

0.36

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1.42

0.36

1.0

1.1

—

Malignant neoplasm of breast, including Hilmo

1.42

0.36

1.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

0.63

0.35

1.0

1.1

—

Other fall from one level to another

1.39

0.35

1.5

1.0

—

Fall on same level involving ice and snow

117

1.28

0.35

1.1

—

Rotator cuff syndrome

1.30

0.34

1.0

1.1

—

Injuries to the hip and thigh

1.33

0.34

1.2

1.1

—

Single spontaneous delivery

0.66

0.34

1.0

1.3

—

Peritonsillar abscess

1.36

0.34

1.2

1.1

—

Epilepsy

1.27

0.32

1.0

1.1

—

Other chronic obstructive pulmonary disease

1.31

0.28

1.1

1.0

—

Oxicams

1.26

0.28

1.0

1.2

—

Hyperplasia of prostate

1.25

0.28

1.0

—

Disorders of vitreous body

1.29

0.27

1.2

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

1.23

0.27

1.1

1.0

—

Degeneration of macula and posterior pole

1.18

0.24

1.1

—

Periapical abscess

0.76

0.22

1.0

1.1

—

Injuries to the neck

1.25

0.22

1.0

1.1

—

Thyrotoxicosis

1.22

0.22

1.0

1.1

—

Superficial injury of lower leg

1.22

0.22

1.0

1.1

—

Type 1 diabetes, wide definition, subgroup 1

1.22

0.22

2.6

1.1

—

Suicide or other Intentional self-harm

1.19

0.21

1.0

1.1

—

Hypertrophic scar

0.00

0.21

0.0

1.2

—

Hypertrophic disorders of skin

0.00

0.21

0.0

1.2

—

Dermatographic urticaria

0.00

0.21

0.0

1.1

—

Schizoaffective disorder

0.00

0.21

0.0

1.1

—

Vestibular neuronitis

0.00

0.21

0.0

1.0

—

Entropion and trichiasis of eyelid

0.00

0.21

0.0

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.21

0.0

1.0

—

Abnormalities of forces of labour

0.00

0.21

0.0

1.1

—

Benign neoplasm of breast

0.00

0.21

0.0

1.1

—

Malignant neoplasm of colon

0.00

0.21

0.0

1.0

—

Assault by bodily force

0.00

0.21

0.0

1.1

—

Other appendicitis

0.00

0.21

0.0

1.1

—

Haemangioma, any site

0.00

0.21

0.0

1.2

—

Haemangioma and lymphangioma, any site

0.00

0.21

0.0

1.2

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.21

0.0

1.2

—

Mandibular retrognathia

0.00

0.21

0.0

1.2

—

Type1 diabetes, definitions combined, early onset

0.00

0.21

0.0

1.2

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.21

0.0

1.0

—

Fracture of forearm

0.76

0.21

1.1

—

Type 1 diabetes, wide definition

1.16

0.21

2.6

1.1

—

0.00

0.21

0.0

1.0

—

Other benign neoplasms of connective and other soft tissue

0.00

0.21

0.0

1.1

—

Non-allergic asthma

0.00

0.21

0.0

1.1

—

Malignant neoplasm of colon, including Hilmo

0.00

0.21

0.0

1.0

—

Other degenerative diseases of the nervous system

1.25

0.20

1.0

1.1

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.20

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

0.20

0.0

1.1

—

Colon adenocarcinoma, helper endpoint

0.00

0.20

0.0

1.0

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.20

0.0

1.1

—

Type 1 diabetes, strict definition

0.00

0.20

0.0

1.1

—

Irritable bowel syndrome

1.25

0.20

1.0

1.1

—

Congenital malformations of cardiac septa

0.00

0.20

0.0

1.0

—

Blepharochalasis

1.22

0.20

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

1.25

0.20

1.1

—

Erosion of teeth , including avohilmo

1.20

0.19

2.3

1.1

—

Retention of urine

1.18

0.19

1.0

—

Abnormalities of heart beat

1.21

0.18

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.21

0.18

1.1

—

COPD related to multimorbidity

1.16

0.17

1.1

1.0

—

Diabetic retinopathy

1.14

0.17

2.1

1.1

—

Cervical disc disorders

1.11

0.17

1.0

—

Fracture at wrist and hand level

0.75

0.17

1.4

1.1

—

Unspecified fall

1.19

0.16

1.0

1.1

—

COPD, hospital admissions

1.14

0.16

1.1

1.0

—

COPD, early/later onset

1.12

0.16

1.1

1.0

—

Primary gonarthrosis, bilateral

1.20

0.15

1.0

1.1

—

Pregnancy with abortive outcome

0.86

0.14

1.2

1.1

—

Glaucoma

0.82

0.14

1.0

1.1

—

Spinal stenosis

1.19

0.13

1.1

1.0

—

Organic, including symptomatic, mental disorders

1.17

0.11

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

1.16

0.10

1.1

1.0

—

Psoriasis

1.04

0.09

1.0

1.1

—

Haemorrhoids and perianal venous thrombosis

1.12

0.09

1.0

1.1

—

Type of accident

1.09

0.08

1.0

1.1

—

Allergic rhinitis

1.04

0.08

1.0

1.1

—

Pure hypercholesterolaemia

1.11

0.08

1.0

1.1

—

Extrapyramidal and movement disorders

1.09

0.08

1.0

1.1

—

Unspecified mental disorder

0.85

0.07

2.0

1.1

—

Hernia of abdominal wall

0.83

0.07

1.0

1.1

—

Chronic sinusitis

0.82

0.07

1.1

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.88

0.07

1.0

1.1

—

Visual disturbances

100

0.90

0.06

1.0

1.1

—

Varicose veins

1.09

0.04

1.1

—

Sciatica+with lumbago

1.07

0.02

1.3

1.1

—

Gonarthrosis, primary, with knee surgery

1.07

0.02

1.0

1.1

—

Gonarthrosis,primary

1.05

0.01

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.04

0.00

1.0

1.1

—

Visual disturbances and blindness

107

1.03

0.00

1.0

1.1

—

Gonarthrosis

1.05

0.00

1.0

1.2

—

Vascular dementia (subcortical)

0.00

0.0

1.0

—

Injuries involving multiple body regions

0.00

0.0

1.0

—

Corneal scars and opacities

0.00

0.0

1.0

—

Other secondary gonarthrosis

0.00

0.0

1.0

—

Other epidermal thickening

0.00

0.0

1.0

—

Other vitreous opacities

0.00

0.0

1.0

—

Single delivery by caesarean section

0.98

0.00

1.0

1.4

—

Other specified and unspecified disorders of eye and adnexa

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Right hemicolectomy

0.00

0.0

1.0

—

Lichen simplex chronicus and prurigo

0.00

0.0

1.0

—

Malignant neoplasm of bladder

0.00

0.0

1.0

—

Asthma and opportunity respiratory infection

0.00

0.0

1.0

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

Sixth [abducent] nerve palsy

0.00

0.0

1.0

—

Unknown and unspecified causes of morbidity

0.00

0.0

1.2

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.0

1.1

—

Olecranon bursitis

0.00

0.0

1.0

—

Isolated proteinuria

0.00

0.0

1.0

—

Unstable angina pectoris

0.98

0.00

1.0

—

Amyloidosis

0.00

0.0

1.0

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.0

1.0

—

Mental and behavioural disorders due to cannabinoids

0.00

0.0

1.0

—

Other congenital malformations of ear

0.00

-0.00

0.0

1.0

—

Paracetamol or NSAID medication

1.01

-0.00

1.0

1.2

—

Intestinal stricture

1.02

-0.00

1.2

1.0

—

Other, unspecified and serous retinal detachments

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of vitreous body

0.98

-0.00

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.00

-0.00

1.0

1.1

—

Benign paroxysmal vertigo

0.98

-0.00

2.4

1.1

—

Sudden idiopathic hearing loss

0.00

-0.00

0.0

1.0

—

Other diseases of peritoneum

0.00

-0.00

0.0

1.0

—

Other disorders of pigmentation

0.00

-0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

1.0

—

Disorders of vestibular function (Vertigo)

0.90

-0.00

2.0

1.1

—

Atrial septal defect, secundum type

0.00

-0.00

0.0

1.0

—

Pustular psoriasis

0.00

-0.00

0.0

1.0

—

Arterial embolism and thrombosis of lower extremity artery

0.00

-0.00

0.0

1.0

—

Varicose veins of other sites

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

-0.00

0.0

1.0

—

Hypermobility syndrome

0.00

-0.00

0.0

1.3

—

Obesity related asthma

0.88

-0.00

1.0

—

Synovial cyst of popliteal space [Baker]

0.00

-0.00

0.0

1.0

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

1.1

—

Gonococcal infection, including avohilmo

0.00

-0.00

0.0

1.0

—

Suppurative otitis media, unspecified

0.00

-0.00

0.0

1.0

—

Diseases of inner ear

0.92

-0.00

1.8

1.1

—

Glucosamine medication

0.98

-0.00

1.0

1.1

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

1.0

—

Ulcerative proctitis

0.00

-0.00

0.0

1.2

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

-0.00

0.0

1.0

—

Other specified/unspecified soft tissue disorders

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Early onset)

0.00

-0.00

0.0

1.0

—

Primary hyperparathyroidism

0.00

-0.00

0.0

1.0

—

Recurrent dislocation and subluxation of joint

0.00

-0.00

0.0

1.1

—

Seronegative juvenile rheumatoid arthritis

0.00

-0.00

0.0

1.2

—

Subacute thyroiditis

0.00

-0.00

0.0

1.2

—

Vasomotor and allergic rhinitis

0.92

-0.00

1.1

1.2

—

Mixed specific developmental disorders

0.00

-0.00

0.0

1.0

—

Complications associated with artificial fertilization

0.00

-0.00

0.0

1.4

—

Dementia, including avohilmo

0.97

-0.00

1.1

1.0

—

Dementia in other diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Gender identity disorders

0.00

-0.00

0.0

1.2

—

Hyperkinetic disorders (excl. ADHD)

0.00

-0.00

0.0

1.0

—

Unspecified abortion

0.00

-0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

-0.00

0.0

1.0

—

Congenital ovarian cysts

0.00

-0.00

0.0

1.1

—

Divergent concomitant strabismus

0.00

-0.00

0.0

1.0

—

Complications following abortion and ectopic and molar pregnancy

0.00

-0.00

0.0

1.0

—

Pregnancy, childbirth and the puerperium

0.93

-0.00

1.0

1.1

—

Glaucoma-related operations

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

0.96

-0.00

1.3

1.0

—

Nonspecific lymphadenitis

0.00

-0.00

0.0

1.0

—

Mixed disorders of conduct and emotions

0.00

-0.00

0.0

1.1

—

Other acute skin changes due to ultraviolet radiation

0.00

-0.00

0.0

1.0

—

Laparoscopic right hemicolectomy

0.00

-0.00

0.0

1.0

—

Anankastic personality disorder

0.00

-0.00

0.0

1.2

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.00

-0.00

0.0

1.1

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.00

-0.00

0.0

1.2

—

Use of selegiline

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving general sensations and perceptions

0.00

-0.00

0.0

1.0

—

Hyperosmolality and hypernatraemia

0.00

-0.00

0.0

1.0

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.00

-0.00

0.0

1.2

—

Gluteal tendinitis

0.00

-0.00

0.0

1.0

—

Small cell lung cancer, helper endpoint

0.00

-0.00

0.0

1.0

—

Internal derangement of knee

0.94

-0.00

1.0

1.1

—

Other disorders of eyelid

0.94

-0.00

1.0

1.1

—

Other peripheral vertigo

0.00

-0.00

0.0

1.0

—

Moderate visual impairment, binocular

0.00

-0.00

0.0

1.0

—

Congenital malformations of aortic and mitral valves

0.00

-0.00

0.0

1.0

—

Dementia due to Parkinson's disease

0.00

-0.00

0.0

1.0

—

Generalized epilepsy, strict definition

0.00

-0.00

0.0

1.0

—

Agoraphobia

0.00

-0.00

0.0

1.2

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.1

—

Sacrococcygeal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

False labour

0.91

-0.00

1.0

1.1

—

Disorders of puberty, all

0.00

-0.00

0.0

1.1

—

Pterygium

0.00

-0.00

0.0

1.0

—

Adrenocortical insufficiency

0.00

-0.00

0.0

1.2

—

Ventricular septal defect, a heart condition

0.00

-0.00

0.0

1.2

—

Presbyopia

0.00

-0.00

0.0

1.0

—

Use of levodopa decarbox-comt-inhibitor

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of scalp and neck

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin, unspecified

0.00

-0.00

0.0

1.0

—

Abnormal findings on examination of urine, without diagnosis

0.00

-0.00

0.0

1.0

—

Type 1 diabetes

1.00

-0.00

2.6

1.1

—

Monoarthritis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Sacroiliitis, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Superficial injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

COPD, hospital admissions 1, only main diagnosis

0.95

-0.00

1.0

—

Female infertility, tubal origin

0.00

-0.00

0.0

1.3

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Impotence

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Small intestine

0.00

-0.00

0.0

1.0

—

Glaucoma suspect

1.00

-0.00

1.0

1.1

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

-0.00

0.0

1.0

—

ILD-related respiratory insufficiency

0.00

-0.00

0.0

1.0

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

-0.00

0.0

1.0

—

Benign neoplasm of middle ear and respiratory system

0.00

-0.00

0.0

1.0

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

-0.00

0.0

1.4

—

Mouth breathing

0.96

-0.00

1.0

1.1

—

Pleural plaque without asbestos

0.00

-0.00

0.0

1.0

—

Lichen simplex chronicus

0.00

-0.00

0.0

1.0

—

Papulosquamous disorders

0.97

-0.00

1.0

1.1

—

Perioral dermatitis

0.00

-0.00

0.0

1.2

—

Other and unspecified psoriasis

0.00

-0.00

0.0

1.0

—

Cardiodefibrillation

0.92

-0.00

1.0

—

Calcific tendinitis of shoulder

0.00

-0.00

0.0

1.0

—

Other enthesopathies

0.89

-0.00

2.6

1.0

—

Radial styloid tenosynovitis [de Quervain]

0.00

-0.00

0.0

1.1

—

Post-traumatic wound infection, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Problems related to social environment

0.00

-0.00

0.0

1.0

—

Benign neoplasm of meninges

0.00

-0.00

0.0

1.0

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

1.0

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin of trunk

0.00

-0.00

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

-0.00

0.0

1.2

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

0.00

-0.00

0.0

1.2

—

L02BX Other hormone antagonists and related agents

0.00

-0.00

0.0

1.0

—

Alcohol-induced chronic pancreatitis

0.00

-0.00

0.0

1.0

—

Other misadventures during surgical and medical care

0.00

-0.00

0.0

1.0

—

Car occupant injured in noncollision transport accident

0.00

-0.00

0.0

1.0

—

Generalized epilepsy

0.00

-0.00

0.0

1.1

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

1.0

—

Respiratory distress of newborn

0.00

-0.00

0.0

1.2

—

Ankyloglossia

0.00

-0.00

0.0

1.1

—

Atrial septal defect

0.00

-0.00

0.0

1.0

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.1

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

0.00

-0.00

0.0

1.2

—

Unspecified misadventure during surgical and medical care

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

0.00

-0.00

0.0

1.0

—

Contact with sharp glass

0.00

-0.00

0.0

1.0

—

Amputation of thigh

0.00

-0.00

0.0

1.0

—

Tobacco use

0.00

-0.00

0.0

1.0

—

Amyloidosis, other/unspecified

0.00

-0.00

0.0

1.0

—

Sub-endpoint used in defining T1D endpoints

0.95

-0.00

2.6

1.1

—

Injury of nerves at wrist and hand level

0.00

-0.00

0.0

1.0

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

-0.00

0.0

1.0

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

-0.00

0.0

1.2

—

Other and unspecified injuries of head

0.00

-0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.0

—

Other and unspecified degenerative diseases of nervous system

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of wrist and hand

0.00

-0.00

0.0

1.1

—

Open wound of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Duodenum

0.00

-0.00

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

1.1

—

Disorders of puberty

0.00

-0.00

0.0

1.0

—

Mixed hyperlipidaemia

0.00

-0.00

0.0

1.0

—

Hyperlipidaemia, other/unspecified

0.96

-0.00

1.0

1.1

—

Optic neuritis

0.00

-0.00

0.0

1.2

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

1.0

—

Use of galantamine

0.00

-0.00

0.0

1.0

—

Unspecified urinary incontinence

0.00

-0.00

0.0

1.1

—

Rubella [German measles], including avohilmo

0.00

-0.00

0.0

1.0

—

Rubella [German measles]

0.00

-0.00

0.0

1.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

-0.00

0.0

1.1

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

-0.00

0.0

1.1

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

0.00

-0.00

0.0

1.0

—

Left ventricular outflow tract obstruction, narrow definition

0.00

-0.00

0.0

1.0

—

Alcohol withdrawal state with delirium

0.00

-0.00

0.0

1.0

—

Scar conditions and fibrosis of skin

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS